Open AccessFDA Approves Vandetanib for Treatment of Medullary Thyroid Cancer
Publication year - 2011
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000397982.68900.bd
Subject(s) - vandetanib , medullary thyroid cancer , medicine , oncology , thyroid cancer , medullary cavity , thyroid , receptor , tyrosine kinase
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom